Page 6,483«..1020..6,4826,4836,4846,485..6,4906,500..»

RX FOR DANGER DEA blocks Florida Walgreens facility from dispensing controlled substances

Posted: Published on September 15th, 2012

By Amy Pavuk, Orlando Sentinel The U.S. Drug Enforcement Administration on Friday banned a Walgreens distribution center in Jupiter from dispensing controlled substances to its pharmacies in Florida and the East Coast, saying the business constituted an "imminent danger" to the public. The DEA said that since 2009, the Jupiter distribution center has been the single-largest distributor of oxycodone products in Florida. An immediate suspension order alleges the distribution center did not have effective controls against the illegal use of controlled substances, DEA reports. The suspension order alleges the facility failed to conduct due diligence "to ensure that the controlled substances were not diverted into other than legitimate channels." "The diversion of pharmaceutical controlled substances is a great concern for the DEA," Mark R. Trouville, the Special Agent in Charge of the Miami division said in a statement. "All DEA Registrants have an obligation to ensure that medications are getting into the hands of legitimate patients, and when they choose to look the other way patients suffer and drug dealers prosper," he stated. "The Miami Field Division will continue to investigate all those who contribute to this intolerable situation and deal with them accordingly." In a statement issued Friday, Walgreens … Continue reading →

Posted in Wholesale Pharmacy | Comments Off on RX FOR DANGER DEA blocks Florida Walgreens facility from dispensing controlled substances

New drug treatment facility proposed for Uptown Butte

Posted: Published on September 15th, 2012

BUTTE, Mont. - A new chemical dependency center could be coming to the Mining City. The Community Counseling and Correctional Service submitted a proposal for the 3-acre, 32-bed facility to be constructed in uptown. People generally don't want to admit if they have a problem with alcoholism or drug addiction. Chemical dependency issues are a rising concern throughout the community. "I think we have a fair number of people that are involved with chemical dependency issues," said Sheriff John Walsh. "I would say a vast majority of people in our detention center have some kind of chemical dependency issue be it drugs or alcohol," Walsh added. Now a better chance at recovery for people struggling with addiction issues could be right around the corner. "I think it's another tool in the tool box for our community to get these people out of the criminal element and into a productive life," Walsh concluded. Some members in the community expressed concern with the idea, saying it could have a negative impact on the surrounding businesses. Read the rest here: New drug treatment facility proposed for Uptown Butte … Continue reading →

Posted in Drug Dependency | Comments Off on New drug treatment facility proposed for Uptown Butte

Cialis Canada Pharmacy Online

Posted: Published on September 15th, 2012

JPAGE_CURRENT_OF_TOTAL Los miembros del movimiento planeaban realizar una ltima concentracin, el jueves en Washington, en el da en que vence el plazo para pagar los impuestos federales. Haba tambin actos locales previstos en Oklahoma, Ohio y otros estados. Unos 273 aos despus del "Motn del Te", Palin dio un mensaje relacionado con los impuestos. Un hombre en la multitud, John Arathuzik, de 69 aos, dijo que nunca haba sido muy activo polticamente sino hasta que vio el rumbo que tomaba el gobierno de Obama. "Creo que yo poda hacer dos cosas: Poda votar en noviembre, algo que har, y dar apoyo a una protesta pacfica sobre la direccin que este pas ha seguido", dijo Arathuzik, ex combatiente, quien mostraba un ejemplar de la Constitucin, recin adquirido. Fue notoria la ausencia del senador Scott Brown, el republicano que en enero gan la banca que durante medio siglo perteneci al icono liberal Edward Kennedy. Scott se excus citando que estaba ocupado en el Congreso. Brown mantuvo una respetuosa distancia durante su campaa en el invierno, preocupado de que lo consideren alineado con los partidarios ms radicales del movimiento Tea Party. Algunos de stos cuestionan la legitimidad de todo, desde el lugar de … Continue reading →

Posted in Online Pharmacy | Comments Off on Cialis Canada Pharmacy Online

Executive Insight Hosts Webinar "The Hospital Pharmacy as a Revenue Center"

Posted: Published on September 15th, 2012

KIRKLAND, Wash., Sept. 14, 2012 /PRNewswire/ --Executive Insight, a publication dedicated to providing health systems with strategies and solutions, will host a webinar with Gary Johnson, Pharm.D., MHA, Chief Pharmacy Officer at the University of Kentucky Medical Center. The webinar, sponsored by Talyst, will discuss the increasing importance of pharmacy technology and how it improves both patient safety and ultimately, a hospital's bottom-line. Dr. Johnson has dedicated his career to improving efficiencies and patient safety. He has been a strong advocate of pharmacy automation for over eight years. Prior to the University of Kentucky, Dr. Johnson was the Director of Pharmacy at the University of Virginia Health System and implemented pharmacy automation to decrease drug expenditures by $7 million. The webinar, "The Hospital Pharmacy as a Revenue Center," will be held on September 18, from 1:00 2:00 p.m. (ET). For more information and to register for the free webinar, visit Executive Insight. About Talyst Talyst is a leader in pharmacy automation and engineers the safer pharmacy. Our solutions provide enterprise-wide medication management across your entire health system to offer greater inventory control, enhanced workflow efficiency, and improved patient safety. As of 2012, Talyst has installed automated systems in more than … Continue reading →

Posted in Pharmacy | Comments Off on Executive Insight Hosts Webinar "The Hospital Pharmacy as a Revenue Center"

University of Kentucky College of Pharmacy pioneer dies

Posted: Published on September 15th, 2012

Joseph V. Swintosky, the dean emeritus at the University of Kentucky College of Pharmacy who officials said led the school to national and international prominence, died Thursday. Dr. Swintosky, of Nicholasville, was 90. Dean of the UK College of Pharmacy from 1967 to 1987, Dr. Swintosky worked to transform pharmacy education and the pharmacy profession, according to a statement from the College of Pharmacy. "The world of pharmacy has lost a giant," Timothy S. Tracy, Dean of the UK College of Pharmacy said in the statement. "Dr. Swintosky placed UK on a trajectory to become one of the nation's top colleges of pharmacy. We would not be the college we are today without his innovative spirit and his commitment to excellence in all we do." Under Dr. Swintosky's leadership, the college was ranked third nationally in the early 1970s and has remained in the Top 10 since that time, the statement said. Dr. Swintosky created the college's master's and Ph.D. programs, a move that cemented UK as a national leader in graduate education and pharmaceutical research. Major transformations in how pharmacy was taught, practiced, and delivered occurred during his tenure, the statement said. UK created the world's first department of … Continue reading →

Posted in Pharmacy | Comments Off on University of Kentucky College of Pharmacy pioneer dies

Omnicare Specialty Care Group to Provide Specialty Pharmacy Services for XENAZINE®

Posted: Published on September 15th, 2012

ORLANDO, September 14, 2012 - Omnicare Specialty Care Group`s specialty pharmacy, Advanced Care Scripts (ACS), has been added to the limited distribution network for Lundbeck`s XENAZINE (tetrabenazine). Xenazine (tetrabenazine) is the only FDA-approved treatment for chorea, or involuntary movements, associated with Huntington`s Disease (HD). Chorea is the hallmark symptom of HD, and studies have shown it affects about 90% of people with the disease. ACS manages and dispenses specialty medications in multiple disease categories, including cancer, infectious diseases, auto-immune disorders, multiple sclerosis and hemophilia. Its expertise across both the specialty and long term care channels allows it to provide comprehensive solutions for prescribers and patients. "As the only approved treatment for Chorea, Xenazine represents an important advancement for patients with Huntington`s Disease," said David Hileman, Senior Vice President of Omnicare Specialty Care Group. "We are pleased to be part of this innovative drug`s limited distribution network and the exclusive provider of product in the long-term care channel. We believe our blister back dispensing model makes us a natural fit to improve the quality of care for this important patient population. Oral blister pack dispensing packaging promotes patient safety and adherence while also reducing the risk of dosing errors through a … Continue reading →

Posted in Pharmacy | Comments Off on Omnicare Specialty Care Group to Provide Specialty Pharmacy Services for XENAZINE®

Proteonomix Announces Agreement with the University of Medicine and Dentistry of New Jersey (UMDNJ) to Conduct a Phase …

Posted: Published on September 15th, 2012

PARAMUS, N.J.--(BUSINESS WIRE)-- Proteonomix, Inc. (OTC/BB: PROT), a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, today announced it has entered into an agreement with Piscataway, N.J.-based University of Medicine and Dentistry of New Jersey (UMDNJ) to conducted a Phase 1 clinical trial with its proprietary, patent-pending mobilization technology UMK-121 in patients with end-stage liver disease (ESLD). The Company also announced that Chief Executive Officer Michael Cohen made a presentation at the National Investment Banking Associations (NIBA) 123rd Investment Conference yesterday at the New York Marriott Downtown in New York City. The single-center Phase 1 clinical trial, Mobilization of Stem Cells with UMK 121 in Patients with Cirrhosis, will enroll 15 patients with ESLD. The trial will study the safety of mobilization of stem cells in this patient population, as well as the effects of mobilization of stems cells from bone marrow to the peripheral circulation on liver function. Baburao Koneru, M.D., Professor and Chief of the Division of Transplant and Hepatobiliary Surgery at New Jersey Medical School, will serve as the trials principal investigator. We are extremely pleased to announce that our trial will be conducted at this highly respected institution … Continue reading →

Posted in Mesenchymal Stem Cells | Comments Off on Proteonomix Announces Agreement with the University of Medicine and Dentistry of New Jersey (UMDNJ) to Conduct a Phase …

Marlee Matlin fears for deaf stem-cell treatment

Posted: Published on September 15th, 2012

British researchers have been able to rebuild nerves in the ears of gerbils, and it is believed the same technique could one day be applicable to deaf humans. However, Oscar-winning actress Matlin, who has been deaf since she was 18 months old, is worried about the implications of the development. In a series of posts on Twitter.com, she writes, "'Deafness cure' is trending (on Twitter). My concern is that it's bigger than a 'trend.' It involves people & not as simple as the 4 letters in 'cure.' For those who think being deaf is a handicap, there are millions of Americans who sign, who are deaf, and are not a 'disease' to cure. "Think about this. What if someone told you that you could've been made different than the content person you are with genetics. Would you? Now think how millions of deaf people who lead productive lives, would feel when told that babies born deaf can be 'cured'." Matlin also told followers, "Be proud of who you are, regardless of what people think is a 'handicap' or 'normal.' Normal is what you want to be. Don't let anyone tell you who or what you should be." More: Marlee Matlin … Continue reading →

Comments Off on Marlee Matlin fears for deaf stem-cell treatment

Compound in cannabis may help treat epilepsy, researchers say

Posted: Published on September 14th, 2012

British researchers have determined that a little-studied chemical in the cannabis plant could lead to effective treatments for epilepsy, with few to no side effects. The team at Britains University of Reading, working with GW Pharmaceuticals and Otsuka Pharmaceuticals, tested cannabidivarin, or CBDV, in rats and mice afflicted with six types of epilepsy and found it strongly suppressed seizures without causing the uncontrollable shaking and other side effects of existing anti-epilepsy drugs. According to the findings, reported this week in the British Journal of Pharmacology,CBDV also delayed and reduced seizures when used in conjunction with two common anti-convulsant drugs. There is a pressing need for better treatments for epilepsy, said Dr. Ben Whalley, the lead researcher. Its a chronic condition with no cure and currently, in around one third of cases, the currently available treatments do not work, cause serious side-effects and increase fatalities. The study, he added, highlights the potential for a solution based on cannabinoid science.It has shown that cannabidivarin is the most effective and best tolerated anticonvulsant plant cannabinoid investigated to date. The casual use of marijuana -- or cannabis -- to control seizures dates back to ancient times. Its most prominent component, THC, is among those … Continue reading →

Comments Off on Compound in cannabis may help treat epilepsy, researchers say

Multiple Sclerosis Pill Approved by U.S. FDA

Posted: Published on September 14th, 2012

The U.S. FDA this week approved a once-a-day pill for the treatment of multiple sclerosis (MS). The pill, being branded as Aubagio by Sanofi S.A., is specifically for the treatment of adults with relapsing forms of MS. In a clinical trial, the relapse rate for patients using Aubagio was about 30 percent lower than the rate for those taking a placebo, said Dr. Russell Katz, director of the division of neurology products in the FDAs Center for Drug Evaluation and Research. Multiple sclerosis can impair movement, sensation, and thinking, so it is important to have a variety of treatment options available to patients. According to the National Institutes of Health, MS is a chronic autoimmune disease that affects the central nervous system. It disrupts the communication between the brain and the body, causing motor skill disruption for nearly every part of the body, depending on which nerves in the brain are damaged. As for the drug itself, side effects seen during drug trials included diarrhea, abnormal liver tests, nausea, and hair loss. Also, the box warnings for the drug warn of possible liver problems and fetal harm, including the risk of birth defects. Doctors will have to check patients liver … Continue reading →

Posted in MS Treatment | Comments Off on Multiple Sclerosis Pill Approved by U.S. FDA

Page 6,483«..1020..6,4826,4836,4846,485..6,4906,500..»